Diagnostic Approach for Enlarging Level II Lymph Nodes

Introduction to Diagnostic Guidelines

The American Academy of Otolaryngology-Head and Neck Surgery recommends urgent imaging with contrast-enhanced CT or MRI of the neck for patients with enlarging level II lymph nodes, followed by fine-needle aspiration (FNA), due to the high risk of malignancy 1

The American Academy of Otolaryngology-Head and Neck Surgery states that patients lacking infectious history with masses present ≥2 weeks without significant fluctuation are at increased risk for malignancy 1
A lymph node size exceeding 1.5 cm is considered a high-risk feature for malignancy, with a size of 2.3 cm indicating a significant risk 1
Progressive enlargement of a lymph node over 12 months without fluctuation indicates a persistent pathologic process, increasing the risk of malignancy 1
The absence of infectious etiology, such as constitutional symptoms or acute infectious symptoms, suggests a higher risk of malignancy 1

The American College of Radiology recommends contrast-enhanced CT or MRI with contrast as the first diagnostic test for enlarging level II lymph nodes, to assess internal characteristics, identify additional pathologic lymph nodes, evaluate primary tumor sites, and determine fixation to adjacent structures 1, 2
The ACR Neck Imaging Reporting and Data Systems (NI-RADS) framework suggests that newly enlarging nodes without definite morphologic abnormalities on CT alone may warrant PET/CT for further characterization 3

Fine-needle aspiration (FNA) should be performed instead of open biopsy as the initial tissue sampling method, with image-guided FNA targeting solid components or the cyst wall if cystic components are present 1, 2
Open excisional biopsy should be avoided before imaging and FNA, as this worsens outcomes if malignancy is present and risks tumor spillage 2

Cystic metastases from HPV-positive oropharyngeal cancer can present as soft masses, and the "soft" texture does not exclude malignancy 2
Papillary thyroid carcinoma commonly metastasizes to level II nodes with cystic degeneration, and up to 80% of cystic neck masses in patients >40 years are malignant 2

Metastatic squamous cell carcinoma from the oropharynx is the most common cause of level II adenopathy in adults, while papillary thyroid carcinoma and lymphoma are also possible diagnoses 2
The absence of constitutional symptoms does not exclude malignancy, as many head and neck cancers present with isolated lymphadenopathy before other symptoms develop 1